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beat-to-beat fluctuations; autonomic control; cardiova regulation; re :nin-angiotens Iin system; conscious dogs scular BEAT-TO-BEATFLUCTUATIONS in hemodynamicparameters reflect both the presence of a variety of naturally occurring physiological perturbations to cardiovascular homeostasis and the dynamic response of the cardiovascular control systems to these perturbations.
For example, cyclic variation of intrathoracic pressure with 0363 -6135/85 $1.50 Copyright 0 1985 the American Physiological Society breathing mechanically perturbs venous return, pulmonary vascular and aortic pressures, while also being coupled to a cyclic variation in heart rate (HR) through a centrally mediated mechanism (4, 5, 8, 9, 16, 23, 24) . Furthermore, the resultant cyclic variation in arterial blood pressure (ABP) impinges on HR through the autonomically mediated baroreceptor reflex (18, 28 ). Another example of a perturbation to cardiovascular homeostasis is fluctuations in peripheral vascular resistance (13, 20) as vascular beds regulate local blood flow to match supply with demand. These fluctuations in peripheral resistance in turn can perturb central blood pressures and, through the baroreceptor reflex, also lead to compensatory variation in HR.
Hyndman, Kitney, Sayers, and Rompelman utilized power spectrum methods to analyze the frequency content of fluctuations in HR and other hemodynamic parameters (17, 21, 27) . They showed that short-term (time scale of seconds to minutes) fluctuations in these parameters were concentrated in three principal spectral peaks (21), as we later confirmed (2; see Fig. 1 ). One peak is centered at the respiratory frequency; this peak shifts with changes in the respiratory rate. The cyclic variation of HR and ABP with respiration was noted by Hales as early as 1733 (14) . The second identifiable spectral peak, the midfrequency peak, occurs typically between 0.1 and 0.15 Hz. Mayer (1876) in fact described such blood pressure waves in animals; these oscillations occurring at 6-9 cycles/min were at a considerably lower frequency than the respiratory frequency (29) . The third peak of the spectrum, identified by Burton (7) and studied by Sayers and co-workers (27) , occurs typically at a central frequency from 0.04 to 0.08 Hz. The work of Hyndman and Kitney (17, 19) related this low-frequency peak to thermoregulatory fluctuations in vasomotor tone, whereas the midfrequency peak was related to the frequency response of the baroreceptor reflex.
In a previous paper (2) we related the spectral properties of the HR fluctuations in the conscious dog to the activity of three cardiovascular control systems: the parasympathetic nervous system, the sympathetic nervous TTmfbm system, and the renin-angiotensin system. We showed that the low-frequency peak in HR fluctuations is mediated jointly by the parasympathetic and sympathetic nervous systems. HR fluctuations occurring at frequencies above roughly 0.1 Hz were mediated solely by the parasympathetic system. Blockade of the renin-angiotensin system led to the dramatic increase in the amplitude of the low-frequency peak. The effects of autonomic blockade were confirmed in humans (26) , and changes in body posture were shown to alter sympathetic-parasympathetic balance as measured by the HR power spectrum.
We interpreted our results (2) in terms of a simple model of the short-term cardiovascular control system (Fig. 2 ). In this model, HR is directly modulated by the sympathetic and parasympathetic nervous systems. Both these systems sense, through a variety of receptors, fluctuations in cardiovascular parameters including arterial and venous pressures, vascular volumes, and correlates of blood flow and oxygenation (3, 6, 10). The parasympathetic system can respond over a wide frequency range, whereas the sympathetic system can only respond at relatively low frequencies below roughly 0.1 Hz (30) . Thus only the parasympathetic system can mediate HR fluctuations above 0.1 Hz, whereas both systems can mediate fluctuations below 0.1 Hz.
We suggest that the fluctuations in vasomotor tone associated with the low-frequency HR fluctuations are not solely related to thermoregulation (17, 19, 20) but also reflect local adjustment of resistance in individual vascular beds that match local blood flow to I ocal meta-AKSELROD ET AL.
bolic demand. Fluctuations in peripheral vasomotor tone lead to fluctuations in central blood pressures that are in turn sensed by pressoreceptors which, through the autonomically mediated baroreceptor reflex (lo), lead to compensatory fluctuations in HR at the corresponding frequency. In addition (22) , the renin-angiotensin system senses blood pressure fluctuations and, through the elaboration of antiotensin II plays the role of the guardian of the overall peripheral vascular resistance. Blockade of the renin-angiotensin system by converting-enzyme inhibitor may remove this damping influence and permit increased fluctuations in blood pressure and increased compensatory fluctuations in HR in the low-frequency regime.
In this paper we examine the physiological sources of fluctuations in HR and ABP, the interactions between fluctuations in HR and ABP, and the role of short-term regulatory systems in controlling these fluctuations. We report changes in the power spectra of HR, ABP, and respiration as a result of autonomic blockade (parasympathetic, P-sympathetic, or a-sympathetic) or blockade of the renin-angiotensin system. We also examine blood pressure variability in the absence of HR variability by means of atria1 pacing.
METHODS

Preparatory
operative procedures.
Seven male dogs (20-30 kg) were utilized in these experiments. Anesthesia was induced by intravenous injection of pentobarbital sodium (25 mg/kg) with supplements given when needed, and an intravenous administration of isotonic saline was begun. The animals were placed on mechanical ventilation, and the chest was opened aseptically through the right fourth intercostal space. One arterial catheter was implanted either in the descending aorta or the femoral artery, two venous catheters were implanted in the azygous vein and the interior vena cava by use of the HerdBarger technique (15) , and bipolar pacing electrodes were placed onto the right atrium. The chest was then closed, and all catheters and electrode cables were tunneled subcutaneously to the back and exteriorized. After placement of a flexible chest tube into the pleural cavity, the pneumothorax was reduced by connecting the outer end of the tube to a vacuum pump. Catheters were flushed with dextrose and filled with a solution of heparin sodium (1,000 U/ml) to prevent clotting. Each dog was fitted with a protective jacket and moved to his cage. Penicillin (500,000 U im) was given daily for 3 days after the operation. Catheters were flushed and filled daily with a solution of heparin sodium (1,000 U/ml). We recorded all signals for 30-min periods preceding and during each of the following five interventions: 1) atria1 pacing, 2) parasympathetic blockade, 3) P-sympathetic blockade, 4) renin-angiotensin system blockade, 5) CYsympathetic blockade, In some experiments two different interventions were combined.
Atria1 pacing was used to enable us to examine fluctuations in ABP in the absence of HR variability. Interventions Z-5 involved pharmacological blockade of specific cardiovascular control systems. Parasympathetic blockade was achieved by means of glycopyrrolate, a peripheral muscarinic blocking agent. Glycopyrrolate was administered as an intravenous 0.4-mg bolus followed by an infusion of 0.2 mg/h. Blockade was verified by lack of HR response to a 0.25mg bolus of urecholine. B-Sympathetic blockade was achieved using propranolol administered as a 5-mg intravenous bolus followed by an infusion at a rate of 15 mg/h. The blockade was verified by lack of response to a O.l-mg/h infusion of isoproterenol. Renin-angiotensin system blockade was achieved by using converting-enzyme inhibitor, SQ 20881 (Teprotide), to block conversion of angiotension I to angiotensin II. Converting-enzyme inhibitor was administered as a IO-mg intravenous bolus followed by an infusion of 5 mg/h. Blockade was verified by lack of response to a Zmg bolus of angiotensin I. a-Sympathetic blockade was achieved by using phentolamine; a 5-mg bolus was administered intravenously followed by a constant infusion of 75 mg/h. Blockade was verified by lack of response to a 0.6-mg bolus of methoxamine.
Data analysis. Spectral analysis of fluctuations in HR, ABP, and respiration was performed off-line on 256 s stationary segments of the ECG and physiological signals recorded on FM tape. The analysis was performed on an 8085 microprocessor based data analysis system. This system has been previously described (1) and will be summarized here. The ECG channel was sampled at a rate of 360 Hz and processed in real time by an algorithm based on feature extraction and clustering to detect and classify QRS complexes and measure R-R intervals. Simultaneously, the other physiological signals were filtered through a ~-HZ, two-pole analog low-pass filter to reduce aliasing and then sampled at 4 Hz. Those samples, interwoven with the R-R interval and beat classification were stored on floppy disk, in real time.
The resultant file, consisting of 256 s worth of data, was then analyzed. A 1,024 point time series of the instantaneous HR also sampled at 4 Hz was computed from the stored R-R interval sequence using a low-pass anti-aliasing digital filter (25) . A 1,024 point time series of ABP and respiration was read off the file. Power spectrum of each 1,024 point time series was computed using a fast Fourier transform-based windowed periodogram method (25) and normalized respectively by the square of mean HR and mean ABP for HR and ABP spectra and not normalized for the respiratory spectrum. ' In addition to these spectral measurements, the ABP 1 Power spectra of heart rate (HR) or arterial blood pressure (ABP) have units of ( HR)2/frequency or (ABP)2/frequency. Division by (mean HR)2 or (mean ABP)2 makes these spectra independent of the units of measurement and expresses fluctuations as fractional variation about the mean. This procedure is entirely equivalent to dividing the original HR and ABP signals by their respective means. The respiratory signal used was proportional to changes in lung volume, but no signal mean was available; therefore no "normalization" was possible. However, mean lung volume, unlike mean HR or mean blood pressure, should not be significantly affected by the interventions used. waveform was analyzed to compute the time constant (7) of the diastolic decay in blood pressure. Changes in the mean values of 7 were used to estimate changes in the peripheral arterial resistance, R, (1 I).
Data presentation.
In Tables 1-5, the results of each  experimental intervention are tabulated; n signifies the number of experiments performed. The left-hand portions present the ratios of mean HR, blood pressure, and peripheral arterial resistance to their values before the intervention, and the significance of these changes computed by use of Student's t test. The right-hand portions of Tables l-5 represent changes in the spectral properties of the fluctuations in HR, ABP, and respiration. Since the midfrequency peak is often poorly detected in the dog, only low-frequency peak area and high-frequency area were computed. The low-frequency peak area was computed by integrating the spectrum from 0.02 and 0.09 Hz. The high-frequency peak area was computed by integrating the spectrum over this peak's entire bandwidth as defined from the power spectrum of the respiratory signal.
The right-hand parts of Tables 1-5 present the changes in the low-frequency and respiratory peak in the different physiological signals such as HR, ABP, and respiration. For each signal of interest (HR, ABP, and respiration), we present the geometric and arithmetic means of the ratios (intervention over control) in each frequency band. We found that the distribution of the natural logarithm of these ratios (x = In r) is much closer to normal than the distribution of r itself. Therefore, in the third column we present JG, the arithmetic mean of z = In r, (equivalently i is the logarithm of the geometrical mean of F). From the values of x we compute standard error of the mean and significance level from the Student's t test presented as SE and P in the tables. (In a small number of experiments in Tables 3 and 4 , the blood pressure respiratory traces were not of adequate quality to carry out the spectral analysis. In these cases the statistics were computed on the basis of the number of traces actually analyzed.) In addition, we compute the ratios of spectral areas HR/resp, ABP/resp, or HR/ABP in both the low-frequency range and the respiratory range. At the lower portions, right-hand side of Tables l-5 the ratio (intervention over control) is presented for each of these quantities.
RESULTS
Pacing. In eleven experiments, atria1 pacing to a mean rate of 130 beats/min, led to a dramatic decrease (to 1% of control) in the respiratory frequency ABP fluctuations; meanwhile, low-frequency ABP fluctuations increased slightly but not significantly (see Fig. 3 and Table  1) 'Parasympathetic blockade. Parasympathetic blockade not only increased mean HR 139% and ABP by 13%, but also had a striking effect on the pattern of fluctuations (Table 2 ). HR and ABP fluctuations decreased significantly at low and even more at respiratory frequencies. The decrease in ABP fluctuations in both frequency bands was not as pronounced as in HR. AKSELROD ET AL. P-Sympathetic blockade. As expected, P-sympathetic blockade with propranolol decreased mean HR (by about 8%) without having any significant effect on mean ABP (Table 3 ) and increased vascular resistance by 18% (12). P-Blockade had only an insignificant effect on HR and ABP fluctuations at the respiratory frequency. However, at low frequency, fluctuations in ABP increased 30% (P < O.OOl), while the HR fluctuations increased 50% (P c 0*02), Blockade of renin-angiotensin system. As expected, converting-enzyme inhibitor decreased vascular resistance: by 17% while mean HR and ABP were unchanged (Table 4) . Converting-enzyme inhibitor caused a significant increase in low-frequency fluctuations, especially in HR but also in ABP. The power spectrum of the fluctuations in both HR and ABP at respiratory frequency are slightly decreased; in the same proportion that respiratory amplitude itself decreased (see Resp row, Table 4 ). Also the administration of converting-enzyme inhibitor during pacing (n = 4) caused a 2.3-fold increase in the low-frequency ABP fluctuations (data not shown). wSympathetic blockade. As expected, (see Table 5 ), CYblockade caused a large decrease in the peripheral resistance (63%). This effect, however, resulted in a negligible change in mean ABP and a 30% increase in HR.
The low-frequency fluctuations in HR increased 3.6-fold, (P < 0.02), while ABP fluctuations were unchanged. In the respiratory frequency range, HR and ABP fluctuations did not change significantly.
In two dogs we gave phentolamine during atria1 pacing (data not shown) and found a 33 and 6% increase in the low-frequency ABP fluctuations.
DISCUSSION
To interpret these results, it is useful to consider the closed-loop feedback system coupling HR and blood pressure fluctuations (see Fig. 4 ). In this figure, x designates HR and y designates ABP. The transfer function Hy describes how fluctuations in HR directly induce fluctuations in blood pressure. Hy" characterizes, therefore, the mechanical properties of the heart and arterial tree. The transfer function Hq describes how fluctuations in blood pressure induce fluctuations in HR. Hxy, therefore characterizes the baroreceptor reflex, combining the effects of the afferent signal from ABP to the vasomotor center and the efferent signals of the parasympathetic and sympathetic nerves to the sinoatrial node.
nY is a noise source that represents all perturbations to ABP pressure other than those that are secondary to HR fluctuations and includes, for example, those fluctuations in ABP that are secondary to fluctuations in peripheral vascular resistance as local vascular beds autoregulate their local resistance. ny also includes the variation in arterial pressure mechanically coupled to respiration through variation in intrathoracic pressure.
All perturbations to HR other than those mediated by the baroreceptor reflex can be represented in a similar way by a noise source, n,. n,, for example, might include the centrally mediated cyclic variation in autonomic inDut to the sinoatrial node. which is coupled to respi- Fig. 4 can be quantified in notes the convolution operator. The general solutions of terms of two coupled equations these equations are not simple. However, if we assume x(t) = h"(t) * y(t) + n&) (l) that in the low-frequency regime n, is negligible while in ABP fluctuations at the respiratory frequency are secondary to the fluctuations in HR and essentially disappear during pacing (see Table 1 ). At low frequencies, fluctuations in HR are primarily driven by variations in peripheral vasomotor activity (2, 19, 21) that perturb peripheral resistance and thus ABP (and possibly central pressures as well). If these assumptions are true then we can show that in the frequency domain, at low frequencies s S*]HXylz xx = 11 -H"YHY"I2 GA ) (3B) where S"" is the power spectrum of HR, Syy is the power spectrum of blood pressure, Sn* is the power spectrum of the noise source nY, and WY (or Hy") denotes the Fourier transform of hxy (or hy"). 11 -HXyHyX 1-l represents the closed-loop gain of the system (from input ny to output y).
Conversely, at high frequencies S nxnx S xx = 11 -HxYpl" s"xh 1 HY" 12 sw = 11 _ H"YHY"I2 (44 w 1
Here 11 -HxyHyx I-' also represents the closed-loop gain (from input n, to output x).
Thus at low frequencies, by dividing Eq. 3B by Eq* 3A Fig. 4 . As a result, the power spectrum of fluctuations in ABP, SW, should just equal the spectrum of fluctuations in ny, Sn+ Of course, the increased HR during pacing might conceivably alter ny from the control state. We see that as a result of pacing, the spectral power in ABP at the respiratory frequency is diminished by two orders of magnitude. This demonstrates that in the normal dog, perhaps contrary to popular belief, respiratory variation in ABP is secondary to HR variation at that frequency. The variation in ABP resulting from purely mechanical effects of variation in intrathoracic pressure on venous return and chamber filling is two orders of magnitude less than the HR effect. In contrast, during atria1 pacing the lowfrequency fluctuations in ABP did not decrease; in fact they increased, but not to a statistically significant degree. This suggests, as per our discussion above, that low-frequency fluctuations in ABP are caused not by variability in HR but by variability in peripheral vasomotor activity (although variability in stroke volume cannot be excluded). The fact that the low-frequency ABP fluctuations do not increase markedly with pacing suggests that the closed-loop gain I 1 -H"yHy"I -' is not very small compared with unity in the low-frequency regime.
Parasympathetic blockade. Parasympathetic blockade essentially abolishes respiratory frequency fluctuations in HR and blood pressure. This confirms that respiratory frequency fluctuations in HR are vagally mediated (i.e., n, goes to 0 with parasympathetic blockade), and that ABP fluctuations in this range are primarily mediated by HR variation (see above, Pacing). The very small residual respiratory frequency variation in ABP observed during pacing or parasympathetic blockade is probably mediated by the mechanical effects of respiration (Eq. 4 therefore no longer applies during pacing or parasympathetic blockade), although we have not at this point excluded the possibility that the sympathetic nervous system might modulate vascular tone or stroke volume at the respiratory frequency.
In the low-frequency range, HR fluctuations are diminished 95% and blood pressure fluctuations are diminished 68%, indicating from Eq. 5A that 1 Hxy12 is reduced sixfold. This indicates that activity is blocked in the parasympathetic limb of the baroreceptor reflex. The reduced magnitude of the ABP fluctuations in the lowfrequency regime suggests that parasympathetic blockade also directly reduces perturbations to ABP (SW), assuming, as indicated by the pacing data, that the closed-loop gain 11 -HxyHy" 1-l does not differ significantly from unity. P-Blockade. In the respiratory frequency regime, @-blockade did not significantly alter HR or blood pressure fluctuations, indicating that the P-sympathetic nervous
